Showing 2961-2970 of 4166 results for "".
- Alcon Contact Lens and Cataract Innovations to Headline Clinical and Educational Program at #Academy19https://modernod.com/news/alcon-contact-lens-and-cataract-innovations-to-headline-clinical-and-educational-program-at-academy19/2477022/Alcon will bring major contact lens and cataract innovations together for the first time at the 2019 American Academy of Optometry (AAO / #Academy19) meeting taking place October 23-27 at the Orange County Convention Center (OCCC) in Orlando, according to a company news release. Innovations like
- Ivantis Announces Publication of Comparative MIGS Clinical Trial Resultshttps://modernod.com/news/ivantis-announces-publication-of-comparative-migs-clinical-trial-results/2476486/Ivantis, developer of the Hydrus Microstent, announced that the 12-month results of the COMPARE study for minimally invasive glaucoma surgery (MIGS) were accepted into the journal Ophthalmology, according to a company news release. COMPARE is the first prospective, multicenter, ra
- Ivantis Announces 24-Month Results of Comparative MIGS Clinical Trialhttps://modernod.com/news/ivantis-announces-24-month-results-of-landmark-prospective-randomized-comparative-migs-clinical-trial/2476379/Ivantis, developer of the Hydrus Microstent, announced the 24-month results of the COMPARE study for minimally invasive glaucoma surgery (MIGS). Results from the study were presented by Thomas Samuelson, MD, President of the American Society of Cataract and Refracti
- Clinical Trials Planned for Iris-Recognition-Based Patient Identification Softwarehttps://modernod.com/news/clinical-trials-planned-for-iris-recognition-based-patient-identification-software/2476333/Patientory and UK-based IrisGuard announced a collaboration to combine leading iris biometric technology and healthcare focused PTOYNet blockchain network for enhanced security measures. The HIPAA-compliant Patientory App, which already adheres to strict security requirements, will utilize the be
- Genentech Unveils New Clinical Data For the First Eye Implant for Wet AMDhttps://modernod.com/news/genentech-unveils-positive-phase-2-results-for-the-first-eye-implant-for-wet-amd/2479987/Genentech announced positive topline results from the phase 2 LADDER study evaluating the efficacy and safety of its investigational Port Delivery System (PDS) with ranibizumab in people with wet age-related macular degeneration (AMD). The small, refillable eye implant, which is slightly l
- Alcon to Present Robust Clinical Program, New Innovations at ASCRShttps://modernod.com/news/alcon-to-present-robust-clinical-program-new-innovations-at-ascrs/2480259/Alcon will showcase advancements in the cataract, glaucoma, and refractive spaces during the American Society of Cataract and Refractive Surgery (ASCRS) 2018 annual meeting, taking place April 13-17 in Washington, D.C. The company will leverage nearly 90 scientific abstract presentations, several
- Luneau Technology Launches as 'Visionix' to Manufacture and Sell Optovue, Visionix, Briot and Weco Brandshttps://modernod.com/news/luneau-technology-launches-as-visionix-to-manufacture-and-sell-optovue-visionix-briot-and-weco-brands/2480736/Luneau Technology Group recently announced that it will take on 'Visionix' as its official global name beginning March 31, 2022, unveiling a combined booth at Vision Expo East. As mentioned in the recent global announcement, 'Optovue' will transition to a product brand f
- HOYA Presents New Data on MiYOSMART iQ Spectacle Lenseshttps://modernod.com/news/hoya-presents-new-data-on-miyosmart-iq-spectacle-lenses/2485625/HOYA Vision Care recently announced interim 6-month data from its randomized controlled clinical trial evaluating the safety and efficacy of MiYOSMART iQ spectacle lenses to treat children 4 to 12 years of age who have progressive myopia. The company’s myopia control solution uses the defocu
- EyeCare4Kids Names Maggie Cline as New CEOhttps://modernod.com/news/eyecare4kids-names-maggie-cline-as-new-ceo/2482838/The non-profit EyeCare4Kids announced the promotion of Maggie Cline, MPH, to Chief Executive Officer (CEO). Ms. Cline joined EyeCare4Kids in 2022 and served as Executive Director Utah, where she oversaw the delivery of more than 50,000 vision services annually at school clinics, community centers
- Allotex Files IDE with FDA for Collagen-Based Corneal Implanthttps://modernod.com/news/allotex-files-ide-with-fda-for-collagen-based-corneal-implant/2482813/Allotex announced the submission of its investigational device exemption (IDE) to the FDA, marking a step toward US clinical trials of the company’s human collagen-based corneal implant, Allo-1. Allo-1 offers a novel approach to near vision enhancement through biolo